CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)

Name: CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)
License: Public Domain

HuidaGene Therapeutics Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

neovascular age-related macular degeneration(namd)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 451543
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.